Hiroko Otsubo
Impact in
- Hematology top 5%
- Platelet Disorders and Treatments
- Hematopoietic Stem Cell Transplantation
- Blood groups and transfusion
- Acute Myeloid Leukemia Research
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Acute Myeloid Leukemia Research 3
- Multiple Myeloma Research and Treatments 3
- Hematopoietic Stem Cell Transplantation 2
-
- Blood transfusion and management 2
- Co-authors
- Ken KaitoMasayuki KobayashiNoriko UsuiMiyuki YoshidaKazunari YamaguchiYoji OgasawaraTatsuo HosoyaKaichi Nishiwaki
In The Last Decade
Hiroko Otsubo
20 papers receiving 346 citations
Peers
Comparison fields: 5 of 75
- Hematology 188
- Internal Medicine 39
- Oncology 156
- Genetics 46
- Biochemistry 18
Countries citing papers authored by Hiroko Otsubo
This map shows the geographic impact of Hiroko Otsubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Otsubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Otsubo more than expected).
Fields of papers citing papers by Hiroko Otsubo
This network shows the impact of papers produced by Hiroko Otsubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Otsubo. The network helps show where Hiroko Otsubo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroko Otsubo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2022 | 0 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 1 | |
| 5 | 2019 | 2 | |
| 6 | Gemtuzumab ozogamicin (GO) in relapsed/refractory patients with acute myeloid leukemia. | 2009 | 1 |
| 7 | 2008 | 1 | |
| 8 | 2008 | 23 | |
| 9 | 2008 | 3 | |
| 10 | 2007 | 2 | |
| 11 | 2007 | 11 | |
| 12 | 2007 | 0 | |
| 13 | 2005 | 3 | |
| 14 | 2005 | 223 | |
| 15 | Th1/Th2 lymphocyte balance in patients with aplastic anemia. | 2004 | 10 |
| 16 | 2003 | 3 | |
| 17 | 2002 | 2 | |
| 18 | 2002 | 6 | |
| 19 | 1998 | 64 | |
| 20 | Superior sagittal sinus thrombosis in a patient with aplastic anemia treated with anabolic steroids. | 1998 | 2 |
About Hiroko Otsubo
Hiroko Otsubo is a scholar working on Hematology, Biochemistry, Geriatrics and Gerontology, Pharmacology and Critical Care and Intensive Care Medicine, having authored 22 papers that have together received 366 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Blood transfusion and management (2 papers), Pharmacy and Medical Practices (2 papers), Hematopoietic Stem Cell Transplantation (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Parasitic Diseases Research and Treatment (1 paper). The work is most often cited by research in Hematology (188 citations), Internal Medicine (39 citations), Oncology (156 citations), Genetics (46 citations) and Biochemistry (18 citations). Hiroko Otsubo has collaborated with scholars based in Japan, Pakistan and Nigeria. Frequent co-authors include Ken Kaito, Masayuki Kobayashi, Noriko Usui, Miyuki Yoshida, Kazunari Yamaguchi, Yoji Ogasawara, Tatsuo Hosoya, Kaichi Nishiwaki, Hidekazu Masuoka and Jiro Minami. Their work appears in journals such as International Journal of Hematology, British Journal of Haematology, Acta Haematologica, Animals and Parasitology International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.